CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä,...

8
CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho, Christina Nielsen, Johanna Ivaska, Yoichi Taya, Shi-Long Lu, Shujun Lin, Edward K.L. Chan, Xiao-Jing Wang, Reidar Grènman, Juergen Kast, Tuula Kallunki, Rosalie Sears, Veli-Matti Kähäri, Jukka Westermarck Cell Volume 130, Issue 1, Pages 51-62 (July 2007) DOI: 10.1016/j.cell.2007.04.044 Copyright © 2007 Elsevier Inc. Terms and Conditions

TAGS:

Transcript of CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä,...

Page 1: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

CIP2A Inhibits PP2A in Human Malignancies 

Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho, Christina Nielsen, Johanna Ivaska, Yoichi Taya, Shi-Long Lu, Shujun Lin, Edward K.L. Chan, Xiao-Jing Wang, Reidar Grènman, Juergen Kast, Tuula

Kallunki, Rosalie Sears, Veli-Matti Kähäri, Jukka Westermarck 

Cell Volume 130, Issue 1, Pages 51-62 (July 2007)

DOI: 10.1016/j.cell.2007.04.044

Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 2: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

Figure 1

Cell 2007 130, 51-62DOI: (10.1016/j.cell.2007.04.044) Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 3: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

Figure 2

Cell 2007 130, 51-62DOI: (10.1016/j.cell.2007.04.044) Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 4: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

Figure 3

Cell 2007 130, 51-62DOI: (10.1016/j.cell.2007.04.044) Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 5: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

Figure 4

Cell 2007 130, 51-62DOI: (10.1016/j.cell.2007.04.044) Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 6: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

Figure 5

Cell 2007 130, 51-62DOI: (10.1016/j.cell.2007.04.044) Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 7: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

Figure 6

Cell 2007 130, 51-62DOI: (10.1016/j.cell.2007.04.044) Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 8: CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Raija Ahola, Hugh Arnold, Trine Böttzauw, Risto Ala-aho,

Figure 7

Cell 2007 130, 51-62DOI: (10.1016/j.cell.2007.04.044) Copyright © 2007 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

R URAL D EVELOPMENT T OURISM /S ERVICES Tutor: Magdaléna Pichlerová Elina Puustinen Heidi Tuominen Petra Vachova Elena Zamcu Paul Ivan Innovation in Nature.

R URAL D EVELOPMENT T OURISM /S ERVICES Tutor: Magdaléna Pichlerová Elina Puustinen Heidi Tuominen Petra Vachova Elena Zamcu Paul Ivan Innovation in Nature.

Enhanced expression of MycN/CIP2A drives neural crest ...Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma

Enhanced expression of MycN/CIP2A drives neural crest ...Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma

CLIMATIC EFFECTS ON PRODUCTION AND QUALITY OF BILBERRIES (VACCINIUM MYRTILLUS) Inger Martinussen 1, Jens Rohloff 2, Eivind Uleberg 1, Olavi Junttila 3,

CLIMATIC EFFECTS ON PRODUCTION AND QUALITY OF BILBERRIES (VACCINIUM MYRTILLUS) Inger Martinussen 1, Jens Rohloff 2, Eivind Uleberg 1, Olavi Junttila 3,

CIP2A expression in high grade prostatic intraepithelial ......intraepithelial neoplasia (HGPIN), the precursor lesion of PC, and association of CIP2A expression with overall survival,

CIP2A expression in high grade prostatic intraepithelial ......intraepithelial neoplasia (HGPIN), the precursor lesion of PC, and association of CIP2A expression with overall survival,

CIP2A, an oncoprotein, is associated with cell ...

CIP2A, an oncoprotein, is associated with cell ...

Mobile Style Guide - BBCdownloads.bbc.co.uk/guidelines/mobile_guide_v1.1_compressed.pdf · BBC Mobile Style Guide - Global Visual Language for the mobile web. Ben Guyer, Riikka Puustinen,

Mobile Style Guide - BBCdownloads.bbc.co.uk/guidelines/mobile_guide_v1.1_compressed.pdf · BBC Mobile Style Guide - Global Visual Language for the mobile web. Ben Guyer, Riikka Puustinen,

Brugada Patient and the Environment: Harmful Factors and Drugs Juhani Junttila, MD Insitute of Clinical Medicine, University of Oulu, Oulu, Finland.

Brugada Patient and the Environment: Harmful Factors and Drugs Juhani Junttila, MD Insitute of Clinical Medicine, University of Oulu, Oulu, Finland.

RESEARCH ARTICLE Open Access CIP2A is a target of ... · RESEARCH ARTICLE Open Access CIP2A is a target of bortezomib in human triple negative breast cancer cells Ling-Ming Tseng1,3,

RESEARCH ARTICLE Open Access CIP2A is a target of ... · RESEARCH ARTICLE Open Access CIP2A is a target of bortezomib in human triple negative breast cancer cells Ling-Ming Tseng1,3,

A vision of the future: ReStoring online resources David Martin and Kaisa Puustinen ESRC National Centre for Research Methods, University of Southampton.

A vision of the future: ReStoring online resources David Martin and Kaisa Puustinen ESRC National Centre for Research Methods, University of Southampton.

Beginners Guide to Lifestyle Business (by Henri Junttila)Henri

Beginners Guide to Lifestyle Business (by Henri Junttila)Henri

Bortezomib Sensitizes HCC Cells to CS-1008, an …mct.aacrjournals.org/content/molcanther/10/5/892.full.pdf · CS-1008 downregulated CIP2A ina concentration- and time-dependent manner,

Bortezomib Sensitizes HCC Cells to CS-1008, an …mct.aacrjournals.org/content/molcanther/10/5/892.full.pdf · CS-1008 downregulated CIP2A ina concentration- and time-dependent manner,

CIP2A Influences Survival in Colon Cancer and Is Critical ... fileCIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression Armin Wiegering1,2*, Christina

CIP2A Influences Survival in Colon Cancer and Is Critical ... fileCIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression Armin Wiegering1,2*, Christina

Masaryk University€¦ · (Ande´n-Papadopoulos and Pantti 2011, 9–10 Pantti and Bakker 2009). For instance, Puustinen and Seppanen (2011, 189–190) conducted 30 qualitative interviews

Masaryk University€¦ · (Ande´n-Papadopoulos and Pantti 2011, 9–10 Pantti and Bakker 2009). For instance, Puustinen and Seppanen (2011, 189–190) conducted 30 qualitative interviews

1. INTRODUCTION...1 VALIDATION OF DIRECT CONTACT CONDENSATION CFD MODELS AGAINST CONDENSATION POOL EXPERIMENT I1.Vesa Tanskanen, I2. Djamel Lakehal, I1. Markku Puustinen I1,Lappeenranta

1. INTRODUCTION...1 VALIDATION OF DIRECT CONTACT CONDENSATION CFD MODELS AGAINST CONDENSATION POOL EXPERIMENT I1.Vesa Tanskanen, I2. Djamel Lakehal, I1. Markku Puustinen I1,Lappeenranta

UNITED STATES DISTRICT COURT SOUTHERN DIVISION ......Case 2:20-cv-13134-LVP-RSW ECF No. 105, PageID.4335 Stefanie Lambert Junttila (P71303) Attorney for Plaintiffs 500 Griswold Street,

UNITED STATES DISTRICT COURT SOUTHERN DIVISION ......Case 2:20-cv-13134-LVP-RSW ECF No. 105, PageID.4335 Stefanie Lambert Junttila (P71303) Attorney for Plaintiffs 500 Griswold Street,

Overexpression of CIP2A in head and neck cutaneous · PDF fileSP228 CIP2a overexpression poster.ppt Author: Mac Created Date: 9/4/2011 10:29:03 PM

Overexpression of CIP2A in head and neck cutaneous · PDF fileSP228 CIP2a overexpression poster.ppt Author: Mac Created Date: 9/4/2011 10:29:03 PM

CIP2A is a prime synthetic-lethal target for BRCA-mutated ...2021/02/08  · 1 CIP2A is a prime synthetic-lethal target for BRCA-mutated cancers Salomé Adam1,†, Silvia Emma Rossi1,†,

CIP2A is a prime synthetic-lethal target for BRCA-mutated ...2021/02/08  · 1 CIP2A is a prime synthetic-lethal target for BRCA-mutated cancers Salomé Adam1,†, Silvia Emma Rossi1,†,

Santeri Junttila (Helsinki) · 2018-02-23 · positio b, d, g : p, t, k, jälkimmäisessä taas pituusoppositio p, t, k: pp, tt, kk. Astevaihtelun ei tarvitse olettaa syntyneen (fonemaattistuneen)

Santeri Junttila (Helsinki) · 2018-02-23 · positio b, d, g : p, t, k, jälkimmäisessä taas pituusoppositio p, t, k: pp, tt, kk. Astevaihtelun ei tarvitse olettaa syntyneen (fonemaattistuneen)

WP3 Final Evaluation Report D034 - health. workforcehealthworkforce.eu/wp-content/uploads/2016/11/... · DELIVERABLE D034 – Version 07 FINAL EVALUATION REPORT _____ WP3 Page 1 Puustinen,

WP3 Final Evaluation Report D034 - health. workforcehealthworkforce.eu/wp-content/uploads/2016/11/... · DELIVERABLE D034 – Version 07 FINAL EVALUATION REPORT _____ WP3 Page 1 Puustinen,

Erkki Räsänen Antti Puustinen, Leif Robertsén, Hannu ... chemistry can help Brown Stock Washing operations Erkki Räsänen Antti Puustinen, Leif Robertsén, Hannu Hämäläinen,

Erkki Räsänen Antti Puustinen, Leif Robertsén, Hannu ... chemistry can help Brown Stock Washing operations Erkki Räsänen Antti Puustinen, Leif Robertsén, Hannu Hämäläinen,